Shields Health Solutions · 14 hours ago
Pharmacy Support Specialist - 466 Lexington Avenue (Office)
Shields Health Solutions is a fast-growing specialty pharmacy team, seeking a motivated Pharmacy Technician. The role involves delivering personalized medication support, collaborating with clinic staff, and managing prescription processes to improve patient care.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Deliver personalized medication support and adherence services to patients
Collaborate with clinic staff (physicians, nurses, etc.) to integrate pharmacy services into patient care
Educate patients on pharmacy benefits and assist with onboarding
Manage prescription refills, prior authorizations, and financial assistance
Maintain accurate documentation and support process improvements
Identify and manage specialty medications and related supplies
Communicate with centralized service teams to ensure continuity of care
Participate in quality initiatives and contribute to operational enhancements
Qualification
Required
State-registered Pharmacy Technician required
Minimum 2 years required in a pharmacy technician role
High School Diploma or GED required
Strong communication skills
Strong organization skills
Strong problem-solving skills
Proficient in Microsoft Office
Empathetic
Dependable
Detail-oriented
Team player
Preferred
National certification (CPhT)
3–5 years preferred in a pharmacy technician role
Experience in transplant, hepatitis C, HIV, infectious disease, or oncology is a plus
Benefits
Competitive salary and bonus potential.
Opportunity to work directly with patients and clinicians.
Mission-driven company improving specialty medication access.
Supportive team environment with growth opportunities.
Commitment to diversity, equity, and inclusion.
Company
Shields Health Solutions
Shields Health Solutions is a specialty pharmacy accelerator that partners with hospitals to develop and manage specialty pharmacy programs.
Funding
Current Stage
Late StageTotal Funding
$3.5BKey Investors
Evernorth
2025-09-02Corporate Round· $3.5B
2025-09-02Acquired
Recent News
2025-10-03
Company data provided by crunchbase